Pfizer COVID-19 vaccine 93% effective at preventing pediatric hospitalizations
![cdc-update](/sites/default/files/styles/900x400/public/2018-07/cdc-update.jpg?itok=0cRUeHuZ)
Two doses of the Pfizer vaccine are 93% effective at preventing COVID-19 hospitalization among children aged 12 to 18, according to a study at 19 pediatric hospitals released today by the Centers for Disease Control and Prevention. The study examined prior vaccination status among 464 patients hospitalized with and without COVID-19 between June and September, when the delta variant was predominant, and found nearly all (97%) of the patients hospitalized with COVID-19 were unvaccinated. The authors said the findings “reinforce the importance of vaccination to protect U.S. youths against severe COVID-19.” The Pfizer vaccine is currently the only COVID-19 vaccine authorized for this age group.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…